e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Respiratory symptoms in primary care populations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone
J. MacQuarrie, F. Lebel (Burlington, Canada)
Source:
International Congress 2014 – Respiratory symptoms in primary care populations
Session:
Respiratory symptoms in primary care populations
Session type:
Thematic Poster Session
Number:
3810
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. MacQuarrie, F. Lebel (Burlington, Canada). Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone. Eur Respir J 2014; 44: Suppl. 58, 3810
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
The effect of pulmonary rehabilitation on non COPD patients
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014
Development of the interstitial lung disease multidiciplinary team meeting 2005-2013
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
The 2000 steps a day challenge: A tailored exercise programme for lung fibrosis patients
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014
Benefits of pulmonary rehabilitation and predictor of changes in exercise capacity for idiopathic pulmonary fibrosis
Source: International Congress 2014 – Latest insights in pulmonary rehabilitation
Year: 2014
Value of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Best posters in physical activity, exercise testing and muscles
Year: 2014
Effects of limb training in symptomatic patients with interstitial lung disease of different severity and etiology: A pilot study
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Feasibility and effects of non-invasive ventilation during pulmonary rehabilitation in patients with hypercapnic interstitial lung disease
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
Impact of an interstitial lung diseases Nurse on the compliance to anti-fibrotic drugs in patients with Idiopathic Pulmonary Fibrosis.
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Evaluation of the need for an Advanced Practice Nurse for COPD patients with a pulmonary exacerbation in Switzerland
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019
Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
COPD detected with screening: Impact on patient management and prognosis
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014
Impact of COPD diagnosis in the face of multi-morbidity: Patients' perspectives
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014
Assessment of public awareness on chronic obstructive pulmonary disease in Slovenia
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014
Repeat pulmonary rehabilitation programmes: Are they beneficial in COPD?
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014
Long-term survival analysis: Pirfenidone compared to standard care for the treatment of patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept